Ella · Brain, behavior, and immunity 2016 · ex vivo laboratory study · n=?

Circadian regulation of human peripheral neutrophils.

Cited 154 times in the scientific literature.

Level 5 - mechanism / opinion, no new human data

Ex vivo human laboratory mechanistic study without clinical trial or cohort design

PubMed 27132055 · doi:10.1016/j.bbi.2016.04.016 · record verified 2026-08-26

What was done

Human peripheral blood neutrophils and mononuclear cells were analyzed ex vivo across different times of day to evaluate molecular and functional circadian regulation. The authors examined the expression and nuclear localization of the core clock protein BMAL1, tracked neutrophil aging and maturation using CXCR4 expression and morphological markers (nuclear segmentation and side-scattering), and measured plasma concentrations of CXCL12. Functional responsiveness across time of day was evaluated by measuring NADPH oxidase components, superoxide anion generation capacity, and phagocytic engulfment of opsonized bacteria.

What was found

The abstract reports no numerical values, exact effect sizes, or statistical metrics. It describes directional findings: - Neutrophils showed low expression and reduced nuclear accumulation of BMAL1 compared to mononuclear cells. - The distribution of young and aged neutrophils in peripheral blood displayed a daily rhythm that synchronized with fluctuations in plasma CXCL12 levels. - Expression of NADPH oxidase core components, superoxide production capacity, and the number of engulfed opsonized bacteria varied by time of day.

Why it matters

The study suggests that daily variations in human neutrophil antimicrobial functions are driven by systemic maturation and trafficking rhythms rather than an intrinsic cellular clock. This distinction helps clarify the mechanisms of diurnal immune fluctuations and informs chronotherapy for inflammatory conditions.

Limits

The abstract reports no sample size, participant demographics, sampling time points, or numerical data. The findings rely on ex vivo functional assays and correlative markers rather than direct in vivo clinical outcomes.

Cited by